Nicotinamide Clinical Trials

4 actively recruiting trials across 2 locations

Also known as: NAM, Niacin (Vitamin B3), Niacinamide, niacinamide

Pipeline

Early 1: 1Phase 2: 2Phase 3: 1

Top Sponsors

Women's College Hospital1
University of Utah1
Rhode Island Hospital1
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau1

Indications

Cancer3
Nicotinamide1
Hepatic Fibrosis1
Overweight and Obese Adults1
Liver Disease1

Other2 trials

Nicotinamide Chemoprevention for Keratinocyte Carcinoma in Solid Organ Transplant Recipients - Pivotal Trial

Phase 3

Study of the Efficacy and Safety of Nicotinamide in Patients With Liver Fibrosis (NICOFIB)

Phase 2

Providence, Rhode Island1 trial

Pilot Trial of Supplemental Vitamin A and Nicotinamide

Rhode Island Hospital

Early 1

Salt Lake City, Utah1 trial

Effects of Nicotinamide in Patients With Chronic Lymphocytic Leukemia With History of Non-melanoma Skin Cancers

Huntsman Cancer Institute at University of Utah

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.